A whole new family of drugs is currently being studied very aggressively for the treatment of MS: Tyrosine kinases Inhibitors. Tyrosine kinases (TYKs) are intracellular enzymes that play a key…
Over the past several months, there has been increased interest in the relationship between the Epstein Barr Virus and multiple sclerosis. A study conducted by a Harvard University research team…
An Interview with Dr. John Corboy, Medical Director of the Rocky Mountain MS Center The DISCO-MS trial โ short for โdiscontinuingโ MS medications โ looked at the question โCan we…
Jessica Ahern grew up in Connecticut and moved to Colorado in 2015. She works as a social worker in Jefferson County to help support families and children who are facing…
An Interview with Dr. Timothly Vollmer InforMS: Many advancements and research in MS are really leading to neuro-reparative therapy. Can you tell us whatโs changed to spur that? Dr. Vollmer:ย I…
An Interview with Christy Dittmar, MS, OTR/L, CDRS. As weโve discussed throughout this issue, fatigue is an extremely common, complex, and challenging problem in MS. Frustratingly, there is no one…
ย Jane was diagnosed with multiple sclerosis twelve years ago at the age of 64. โFirst I experienced numbness in my feet and then it progressed to my leg. After seeing…
Palliative Care is an approach to treating serious and chronic illnesses through a holistic, team-based approach. Neuro-palliative Care is an extension of this discipline that deals specifically with neurological diseases…
ย As we all navigate these difficult times, many individuals are experiencing issues with mental health. We recently talked with Elissa Berlinger, Licensed Clinical Social Worker, MS counselor and educator, to…
We recently spoke with Elissa Berlinger, Licensed Clinical Social Worker and MS counselor and educator to reflect on the challenges of the past fifteen months, and to talk about navigating…